Source · Prevention of Future Deaths

Doreen Willis

Ref: 2017-0439 Date: 11 Jul 2017 Coroner: Ian Arrow Area: Plymouth Torbay and South Devon Responses identified: 1 / 1 View PDF

Concerns relate to key learning points from a Root Cause Analysis report on care homes, urging the CQC to review its inspection practices in light of these findings.

Date 11 Jul 2017
56-day deadline 5 Sep 2017
Responses identified 1 of 1
Hospital Death (Clinical Procedures and medical management) related deaths

Coroner's concerns

AI summary
Concerns relate to key learning points from a Root Cause Analysis report on care homes, urging the CQC to review its inspection practices in light of these findings.
View full coroner's concerns
In the circumstances it is my statutory to report to you: At the conclusion of the Inquest asked who presented evidence in connection with the Root Cause Analysis Report to summarise the key areas of learning identified. am attaching her letter to my ffice of the 22 June 2017. would ask you please to have regard to those recommendations when your organisation carries out future inspections of care homes. Would you kindly review the nature of CQC inspections in the light of learning points. Derriford Park, Derriford Business Park, Plymouth, PL6 SQZ Tel 01752 204636 Fax for yet duty key

Responses

1 respondent
Torbay and South Devon NHS Trust NHS / Health Body
PDF
Noted

The trust summarises the key learning outcomes from the agency review, pertaining to medicine management policies and processes for care homes. It references NICE guidance and the Electronic Transfer of Prescriptions (EPS) systems being introduced. (AI summary)

View full response
Dear Mr Arrow Following the inquest held on 5ih June 2017 in relation to the death of Mrs Doreen Willis, you have requested that the key learning outcomes pertaining to the care homes which were identified from the agency review are summarised: This will enable you to provide a report to the Care Quality Commission (CQC) sharing the learning that can be taken forward by care homes in relation to the medicines management processes within their settings. Please find below the areas of learning identified: Care homes must have appropriate medicines management policies and processes in place to ensure the timely and safe ordering, receipt, administration and recording of medicines management for their individual residents_ This should include all aspects of medicines reconciliation at each point or care transferltransaction. AIl staff within the care home involved in medicines management; including administration; are responsible for monitoring and checking the availability of ALL medicines required for individual residents_ Where a medicine is not available for administration there must be a clear process understood by all staff, of what actions and recording of actions should be taken to ensure the medicine is obtained as soon as possible. AIl actions in relation to medicines management must be recorded in the individuals care record and when a residents care transfers to another care provider the manager or responsible person should co-ordinate an accurate listing of all the resident's medicines as part of the onwards needs assessment and care plan: NICE guidance SC1 provides recommendations for good practice on the systems and processes for managing medicines in care homes and care homes should ensure their policies and processes align with this htts Ilniceorguklquidancelscl The introduction of Electronic Transfer of Prescriptions (EPS) systems are now being introduced across primary and community care settings and this reduces the risk of error at points of transferlhandover: This system reduces the need for fax or paper transfers and gives a full audit trail for each individual prescription. Care homes should be recommended to utilise electronic methods for ordering; receipt and reconciliation of medicines as a way of promoting resident safety in effective medicines management multi-_ key

We hope this information provides you with the learning from the multi-agency review undertaken:

Report sections

Investigation and inquest
On 16/06/2015 commenced an investigation into the death of Doreen Willis, 80. The investigation concluded at the end of the inquest on 6 June 2017 The conclusion of the inquest was NARRATIVE The deceased has a history of strokes due to clotting: Her risk of stroke was approximately g% per year. This risk was mitigated by taking the medication Rivoroxiban For a period of time she did not receive Rivoroxiban: The absence of Rivoroxiban may have contributed to her death: She died at Belle Vue Care Home, Paignton on 9 June 2015. Massive Cerebral Vascular Accident
Circumstances of the death
Reporting as safeguarding issues (as discussed by next of kin originally) Lady was admitted to TBH on 7/05/15 with a stroke then transferred to Brixham Hospital on 22/05/15. On 03/06/15 she was discharged to Belle Vue for end of life care. Prior to that she had been at Primley Court Nursing Home since 02/04/15 having been discharged there from Brixham Hospital. Vaguely aware that at Primley Court she was not given her Rivoroxiban: Had been seen by her previous surgery and notes not with new surgery states cause of death ista) Stroke
Action should be taken
In my opinion action should be taken to prevent future deaths and believe you have the power to take such action: YouR RESPONSE You are under a to respond to this report within 56 days of the date of this report, namely by 5 September 2017. I, the coroner, may extend the period. Your response must contain details of action taken or proposed to be taken, setting out the timetable for action. Otherwise you must explain why no action is proposed:

Similar PFD reports

Shared signals

Related inquiry recommendations

Similar themes

Report details

Reference
2017-0439
Date of report
11 July 2017
Coroner
Ian Arrow
Coroner area
Plymouth Torbay and South Devon

Responses identified

Responses identified 1 of 1
All listed responses identified

Organisations named in PFD reports are normally expected to respond within 56 days. Deadline: 5 Sep 2017.

Sent to

Care Quality Commission

Source links